ATE155490T1 - Monoklonale antikörper gegen neue faktor-viii gerinnungspolypeptide - Google Patents

Monoklonale antikörper gegen neue faktor-viii gerinnungspolypeptide

Info

Publication number
ATE155490T1
ATE155490T1 AT93108007T AT93108007T ATE155490T1 AT E155490 T1 ATE155490 T1 AT E155490T1 AT 93108007 T AT93108007 T AT 93108007T AT 93108007 T AT93108007 T AT 93108007T AT E155490 T1 ATE155490 T1 AT E155490T1
Authority
AT
Austria
Prior art keywords
polypeptides
reacts
factor viii
those
react
Prior art date
Application number
AT93108007T
Other languages
English (en)
Inventor
Theodore S Zimmerman
Carol A Fulcher
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27046849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE155490(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE155490T1 publication Critical patent/ATE155490T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
AT93108007T 1983-03-31 1984-04-02 Monoklonale antikörper gegen neue faktor-viii gerinnungspolypeptide ATE155490T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48110583A 1983-03-31 1983-03-31
US55650883A 1983-11-30 1983-11-30

Publications (1)

Publication Number Publication Date
ATE155490T1 true ATE155490T1 (de) 1997-08-15

Family

ID=27046849

Family Applications (2)

Application Number Title Priority Date Filing Date
AT93108007T ATE155490T1 (de) 1983-03-31 1984-04-02 Monoklonale antikörper gegen neue faktor-viii gerinnungspolypeptide
AT84103630T ATE135400T1 (de) 1983-03-31 1984-04-02 Neue faktor viii polypeptidkoagulantien

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT84103630T ATE135400T1 (de) 1983-03-31 1984-04-02 Neue faktor viii polypeptidkoagulantien

Country Status (12)

Country Link
EP (3) EP0770396A3 (de)
JP (2) JPH0829089B2 (de)
AT (2) ATE155490T1 (de)
AU (1) AU572128B2 (de)
CA (1) CA1341506C (de)
DE (2) DE3486453T2 (de)
DK (2) DK172036B1 (de)
FI (1) FI841281A (de)
IE (2) IE80858B1 (de)
NO (1) NO167533C (de)
SG (2) SG49675A1 (de)
ZA (1) ZA842418B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657894A (en) * 1983-03-31 1987-04-14 Scripps Clinic & Research Foundation New factor VIII coagulant polypeptides
US4716117A (en) * 1984-10-26 1987-12-29 Chiron Corporation Monoclonal antibodies to factor VIIIC
DK13485A (da) * 1984-01-12 1985-07-13 Chiron Corp Hybridomacellelinie og monoklonalt antistof opnaaet ved hjaelp af en saadan cellelinie
US7138505B1 (en) 1984-01-12 2006-11-21 Novartis Vaccines And Diagnostics, Inc. Factor VIII:C nucleic acid molecules
US5004804A (en) * 1984-01-12 1991-04-02 Nordisk Gentofte Method and composition for preparation of factor VIIIC
DE3586402T3 (de) * 1984-01-12 2004-12-23 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Proteinzusammensetzung mit Koagulations-wirkung und Verfahren zu ihrer Herstellung.
US5045455A (en) * 1984-01-12 1991-09-03 Chiron Corporation Factor VIII:C cDNA cloning and expression
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
FI86885C (fi) * 1984-04-20 1992-10-26 Genentech Inc Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
KR910006424B1 (ko) * 1985-08-21 1991-08-24 인코텍스 비.브이 편성브리프(brief) 제조방법
EP0272304B1 (de) * 1986-06-24 1994-01-26 Novo Nordisk A/S Verfahren zur herstellung eines koagulationsaktiven komplexes vom faktor viii-fragment
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
EP0294910B1 (de) 1987-06-12 1996-09-11 Immuno Ag Proteine mit Faktor-VIII-Aktivität, Verfahren zu deren Herstellung unter Verwendung von genetisch modifizierten Zellen und diese enthaltende pharmazeutische Zusammensetzungen
IL88309A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides for use in the purification of factor viii
FR2662166A1 (fr) * 1990-05-18 1991-11-22 Fondation Nale Transfusion San Procede de preparation de facteur viii de tres haute purete comprenant une etape rapide d'immunoadsorption.
WO1995003332A1 (en) * 1993-07-23 1995-02-02 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
JP5149470B2 (ja) 1999-02-22 2013-02-20 バクスター・インターナショナル・インコーポレイテッド 新規のアルブミンを含有していない第ｖｉｉｉ因子処方物
EP1418810A4 (de) 2001-08-03 2006-08-02 Us Gov Health & Human Serv Orale behandlung von hämophilie
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364937A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human T cell antigen and methods of preparing same
US4364936A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human monocyte antigen and methods of preparing same
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C

Also Published As

Publication number Publication date
IE840788L (en) 1984-09-30
IE960783L (en) 1984-09-30
DK174984A (da) 1984-10-01
DK174984D0 (da) 1984-03-30
DE3486453D1 (de) 1997-08-21
DE3486453T2 (de) 1998-02-26
SG49675A1 (en) 1998-06-15
EP0770396A2 (de) 1997-05-02
ATE135400T1 (de) 1996-03-15
EP0561427A1 (de) 1993-09-22
AU572128B2 (en) 1988-05-05
NO167533C (no) 1991-11-13
DE3486423T3 (de) 2001-02-08
AU2627284A (en) 1984-10-04
CA1341506C (en) 2006-06-06
FI841281A0 (fi) 1984-03-30
NO167533B (no) 1991-08-05
IE80638B1 (en) 1998-10-21
JPH0829089B2 (ja) 1996-03-27
IE80858B1 (en) 1999-04-21
ZA842418B (en) 1984-11-28
FI841281A (fi) 1984-10-01
EP0123945B2 (de) 2000-04-19
DK50497A (da) 1997-05-02
SG48229A1 (en) 1998-04-17
JPS59184130A (ja) 1984-10-19
EP0123945A1 (de) 1984-11-07
DK172036B1 (da) 1997-09-22
DE3486423T2 (de) 1996-09-19
DE3486423D1 (de) 1996-04-18
JPH0638790A (ja) 1994-02-15
EP0561427B1 (de) 1997-07-16
NO841277L (no) 1984-10-01
EP0770396A3 (de) 1997-07-23
EP0123945B1 (de) 1996-03-13

Similar Documents

Publication Publication Date Title
ATE155490T1 (de) Monoklonale antikörper gegen neue faktor-viii gerinnungspolypeptide
DE3689734D1 (de) Gereinigter immunoglobulinbezüglicher Faktor, monoklonale Antikörper, Hybridoma-Zellinien, Verfahren und Verwendungen.
FR2503145B1 (fr) Peptides apparentes aux interferons humains, anticorps obtenus a partir de ces peptides et adsorbants obtenus a partir de ces anticorps
FR2715664B1 (fr) Baculovirus recombinant et son utilisation pour la production d'anticorps monoclonaux.
IL73883A (en) Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
WO1999062526A3 (en) Use of genetically engineered antibodies to cd38 to treat multiple myeloma
ATE110084T1 (de) Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung.
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
DE3582358D1 (de) Monoklonaler antikoerper und verfahren zur quantitativen bestimmung von immunoglobulinen mittels dieses antikoerpers.
DE3580382D1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
EP0102601A3 (de) Monoklonaler Antikörper, Verfahren zu seiner Herstellung und Verwendung dieses monoklonalen Antikörpers
KR870004137A (ko) 항인간 인터로이킨 1항체(Anti Hunam Interleukin 1 Antibody)와 그의 제법 및 그의 사용법
DK105085D0 (da) Monoklonalt antistof samt hybridom-cellelinie, der udskiller dette
DE3583296D1 (de) Oncofetal spezifische monoklonale antikoerper, deren herstellung und verwendung.
ATE62709T1 (de) Monoklonale antikoerper.
AU590688B2 (en) Monoclonal antibody to HLI and its use for purifying HLI
DE3579808D1 (de) Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung.
NO168969C (no) Fremgangsmaate for affinitetsrensing av et hybrid monoklonalt antistoff, fremgangsmaate for dets fremstilling og anvendelse av antistoffet
RU2000103038A (ru) Специфичные анкроду моноклональные антитела, фрагменты антител, их смеси или производные
EP0089771A3 (de) ATCC HB 8116 und sein monoklonaler anti-h-y Antikörper, hyklonalan
NZ228194A (en) Monoclonal antibodies which bind to the n-terminal peptide sequence of the betasubunit of human haemoglobiin
KR960023044A (ko) 재조합 인간 에리스로포이에틴에 대한 단일클론항체 및 이를 생산하는 신규의 융합세포주
BG46674A1 (en) Hybridom cell line mus musculus vsp- 1e7 secreting monoclonal antibodies against virus of classical plague
EP0349258A3 (de) Verfahren zur Bestimmung der Differenzierung einer menschlichen T-Zelle
ATE64616T1 (de) Oncofetal spezifische monoklonale antikoerper, deren herstellung und verwendung.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time